Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 50090-5985

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 50090-5985). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure Less Than 140 Mmhg At Week 8 (Image 01)

Figure 1: Probability Of Achieving Systolic Blood Pressure Less Than 140 Mmhg At Week 8 (Image 01)
This is a chart that shows blood pressure measurements. The goal blood pressure is less than 140 mmHg. There are two medication doses listed, 100 and 200 mg. A medication called Hydrochlorothiazide is also listed with a dose of 25 mg. There is a baseline SBP measurement in mmHg.*
FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure Less Than 90 Mmhg At Week 8 (Image 02)

Figure 2: Probability Of Achieving Diastolic Blood Pressure Less Than 90 Mmhg At Week 8 (Image 02)
FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure Less Than 130 Mmhg At Week 8 (Image 03)

Figure 3: Probability Of Achieving Systolic Blood Pressure Less Than 130 Mmhg At Week 8 (Image 03)
FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure Less Than 80 Mmhg At Week 8 (Image 04)

Figure 4: Probability Of Achieving Diastolic Blood Pressure Less Than 80 Mmhg At Week 8 (Image 04)
This is a medical document that lists the names and dosages of Valsartan and Hydrochlorothiazide, two medications used to treat high blood pressure. The text also includes a measurement of DBP (diastolic blood pressure) taken before treatment.*
FDA Label Image

Valsartan Structural Formula (Image 05)

Valsartan Structural Formula (Image 05)
FDA Label Image

Hydrochlorothiazide Structural Formula (Image 06)

Hydrochlorothiazide Structural Formula (Image 06)
FDA Label Image

Label Image (Lbl500905985)

Label Image (Lbl500905985)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.